Development
AstraZeneca PLC
AZN
$73.01
$0.130.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.86B | 5.12B | 5.81B | 6.46B | 6.24B |
| Total Receivables | 11.94B | 12.00B | 11.93B | 10.80B | 9.92B |
| Inventory | 5.42B | 5.29B | 5.05B | 4.97B | 4.70B |
| Prepaid Expenses | 1.62B | -- | -- | -- | 1.33B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 218.00M | 97.00M | 44.00M | 40.00M | 398.00M |
| Total Current Assets | 25.05B | 22.50B | 22.84B | 22.27B | 22.59B |
|
|
|||||
| Total Current Assets | 25.05B | 22.50B | 22.84B | 22.27B | 22.59B |
| Net Property, Plant & Equipment | 10.50B | 9.70B | 9.62B | 9.60B | 9.45B |
| Long-term Investments | 20.05B | 19.94B | 19.96B | 20.00B | 19.82B |
| Goodwill | 20.05B | 19.94B | 19.96B | 20.00B | 19.82B |
| Total Other Intangibles | 38.09B | 37.69B | 38.33B | 39.29B | 39.31B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.65B | 4.97B | 4.65B | 4.30B | 4.17B |
| Total Assets | 101.12B | 96.09B | 96.54B | 96.69B | 96.48B |
|
|
|||||
| Total Accounts Payable | 3.27B | 19.72B | 18.93B | 18.42B | 2.55B |
| Total Accrued Expenses | 15.74B | -- | -- | -- | 13.43B |
| Short-term Debt | 5.13B | 515.00M | 421.00M | 667.00M | 5.31B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.26B | 5.99B | 5.25B | 4.03B | 1.19B |
| Total Finance Division Other Current Liabilities | 5.14B | 2.36B | 1.77B | 1.75B | 3.81B |
| Total Other Current Liabilities | 5.14B | 2.36B | 1.77B | 1.75B | 3.81B |
| Total Current Liabilities | 30.54B | 28.59B | 26.38B | 24.86B | 26.29B |
|
|
|||||
| Total Current Liabilities | 30.54B | 28.59B | 26.38B | 24.86B | 26.29B |
| Long-Term Debt | 22.40B | 22.30B | 24.40B | 27.05B | 23.91B |
| Short-term Debt | 5.13B | 515.00M | 421.00M | 667.00M | 5.31B |
| Capital Leases | 857.00M | 744.00M | 722.00M | 730.00M | 725.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.15B | 7.23B | 7.63B | 8.24B | 8.50B |
| Total Liabilities | 61.95B | 58.87B | 59.13B | 60.88B | 59.43B |
|
|
|||||
| Common Stock & APIC | 35.58B | 35.55B | 35.55B | 35.55B | 35.54B |
| Retained Earnings | 4.52B | -434.00M | -234.00M | -1.83B | 3.12B |
| Treasury Stock & Other | -949.00M | 2.08B | 2.08B | 2.07B | -1.63B |
| Total Common Equity | 39.14B | 37.20B | 37.39B | 35.79B | 37.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 39.14B | 37.20B | 37.39B | 35.79B | 37.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 23.00M | 24.00M | 24.00M | 22.00M | 21.00M |
| Total Equity | 39.17B | 37.22B | 37.42B | 35.81B | 37.06B |
|
|
|||||